CTM-N2D

· CytoMed Therapeutics Pte Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CTM-N2D, covering 2024-11-22 to 2024-11-22. Get the full timeline:

Most recent: Clinical Trial Update: Allogeneic NKG2DL-targeting CAR γδ T Cells (CTM-N2D) in Advanced Cancers (ANGELICA) [Phase 1]